Splenectomy: Does it still play a role in the management of thrombotic thrombocytopenic purpura?

Canadian Journal of Surgery

Volumn 53, Issue 5, 2010, Pages 349-355

  Dubois, Luc ^a,b   Gray, Daryl K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CASE REPORT; FEMALE; HUMAN; LAPAROSCOPY; MALE; MIDDLE AGED; RECURRENT DISEASE; REVIEW; SPLENECTOMY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE; SPLENECTOMY; TREATMENT OUTCOME;

EID: 77958165864     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006;354:1927-1935
2. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393-397
3. Bell WR, Braine HG, Ness PM, et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991;325:398-403.
4. Onundarson PT, Rowe JM, Heal JM, et al. Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution. Arch Intern Med 1992; 152: 791-796
5. Kappers-Klunne MC, Wijermans P, Fijnheer R, et al. Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 2005;130:768-776
6. Bukowski RM, King JW, Hewlett JS. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 1977;50:413-417
7. Liu ET, Linker CA, Shuman MA. Management of treatment failures in thrombotic thrombocytopenic purpura. Am J Hematol 1986;23: 347-361
8. Wells AD, Majumdar G, Slater NG, et al. Role of splenectomy as a salvage procedure in thrombotic thrombocytopenic purpura. Br J Surg 1991;78:1389-1390
9. Eldor A, Moser AM, Rose M, et al. Thrombotic thrombocytopenic purpura: The Israeli experience. Transfus Sci 1992;13:53-57
10. Hoffkes HG, Weber F, Uppenkamp M, et al. Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange. Semin Thromb Hemost 1995;21:161-165
11. Veltman GA, Brand A, Leeksma OC, et al. The role of splenectomy in the treatment of relapsing thrombotic thrombocytopenic purpura. Ann Hematol 1995;70:231-236
12. Crowther MA, Heddle N, Hayward CP, et al. Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Ann Intern Med 1996;125: 294-296
13. Rund D, Schaap T, Gillis S. Intensive plasmapheresis for severe thrombotic thrombocytopenic purpura: Long-term clinical outcome. J Clin Apher 1997;12:194-195
14. De La Rubia J, Garcia I, Jarque I, et al. Splenectomy in patients with refractory or relapsing thrombotic thrombocytopenic purpura. Haematologica 2000;85:440-441
15. Schwartz J, Eldor A, Szold A. Laparoscopic splenectomy in patients with refractory or relapsing thrombotic thrombocytopenic purpura. Arch Surg 2001;136:1236-1238, discussion 1239.
16. Wichmann MW, Meyer G, Hiller E, et al. Laparoscopic splenectomy in thrombotic thrombocytopenic purpura. Surgical and hematological results in 2 patients [Article in German]. Dtsch Med Wochenschr 2001;126:299-302.
17. Modic M, Cernelc P, Zver S. Splenectomy: The last option of immunosuppressive therapy in patients with chronic or relapsing idiopathic thrombotic thrombocytopenic purpura? Transplant Proc 2002;34:2953-2954
18. Essien FA, Ojeda HF, Salameh JR, et al. Laparoscopic splenectomy for chronic recurrent thrombotic thrombocytopenic purpura. Surg Laparosc Endosc Percutan Tech 2003;13:218-221
19. Aqui NA, Stein SH, Konkle BA, et al. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. J Clin Apher 2003;18:51-54
20. Zomas A, Gigantes S, Vasiloglou G, et al. Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS [abstract]. J Thromb Haemost 2003;1(Suppl):326.
21. Kremer Hovinga JA, Studt JD, Demarmels Biasiutti F, et al. Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura. Haematologica 2004;89:320-324
22. Outschoorn UM, Ferber A. Outcomes in the treatment of thrombotic thrombocytopenic purpura with splenectomy: A retrospective cohort study. Am J Hematol 2006;81:895-900.
23. Thompson HW, McCarthy LJ. Thrombotic thrombocytopenic purpura. Potential benefit of splenectomy after plasma exchange. Arch Intern Med 1983;143:2117-2119
24. EVans TL, Winkelstein A, Zeigler ZR, et al. Thrombotic thrombocytopenic purpura: Clinical course and response to therapy in eight patients. Am J Hematol 1984;17:401-407
25. SchneiDer PA, Rayner AA, Linker CA, et al. The role of splenectomy in multimodality treatment of thrombotic thrombocytopenic purpura. Ann Surg 1985;202:318-322
26. Hayward CP, Sutton DM, Carter WH Jr., et al. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpurahemolytic uremic syndrome. Arch Intern Med 1994;154:982-987
27. Winslow GA, Nelson EW. Thrombotic thrombocytopenic purpura: Indications for and results of splenectomy. Am J Surg 1995;170:558-61, discussion 561-563
28. Mant MJ, Turner AR, Bruce D, et al. Splenectomy during partial remission in thrombotic thrombocytopenic purpura with prolonged plasma exchange DepenDency. Am J Hematol 1999;62:56-57
29. Rosen M, Brody F, Walsh RM, et al. Outcome of laparoscopic splenectomy based on hematologic indication. Surg Endosc 2002;16:272-279
30. Cuttner J. Splenectomy, steroids, and Dextran 70 in thrombotic thrombo cytopenic purpura. JAMA 1974;227:397-402.
31. Cuttner J. Thrombotic thrombocytopenic purpura: A ten-year experience. Blood 1980;56:302-306
32. Rutkow IM. Thrombotic thrombocytopenic purpura (TTP) and splenectomy: A current appraisal. Ann Surg 1978;188:701-705
33. Bukowski RM, Hewlett JS, Reimer RR, et al. Therapy of thrombotic thrombocytopenic purpura: An overview. Semin Thromb Hemost 1981; 7:1-8.
34. Bernard RP, Bauman AW, Schwartz SI. Splenectomy for thrombotic thrombocytopenic purpura. Ann Surg 1969;169:616-624
35. Rice L. Splenectomy for relapsing thrombotic thrombocytopenic purpura. Ann Intern Med 1997;126:915.
36. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594
37. Furlan M, Robles R, Solenthaler M, et al. Acquired Deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 1998;91:2839-2846 (Pubitemid 28227534)
38. Vesely SK, George JN, Lammle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;102:60-68
39. Zheng XL, Kaufman RM, Goodnough LT, et al. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004;103:4043-4049
40. Scully M, Cohen H, Cavenagh J, et al. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Br J Haematol 2007;136:451-461
41. George JN, Woodson RD, Kiss JE, et al. Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorDers. J Clin Apher 2006;21:49-56.
42. Millward PM, Bandarenko N, Chang PP, et al. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab. Transfusion 2005;45:1481-1486